Cannabis
Will Germany Bow to EU and Scale Back Legalization?
Germany was super excited when it announced plans for a recreational cannabis legalization last May. Since that time, problems surfaced concerning EU regulation, and whether Germany would face obstacles in that direction. While some in the country want to push through, it seems Germany is likely to bow to EU pressure; and greatly scale back its original plan. A new draft law is now anticipated after Easter. What should we expect?
What we know
No one knows for sure what Germany is about to do, and we won’t until right after Easter. But recent issues concerning EU regulation have certainly taken the steam out of the sales. The legislation is already late for submission, and was originally planned for release by the end of the first quarter of 2023. Karl Lauterbach, the German health minister, says that the plan is to release a new draft after Easter; though we have no confirmation on what this means.
The reason for confusion stems from issues Germany has run up against as a member of the EU, since its looking to break with EU mandate. Whereas a few months ago there was a great desire to push back by many lawmakers (and still is), last month it was indicated that the bill might get scaled back in an effort to not deal with international legal issues. So far, the only thing confirmed by Lauterbach, is that “legalization is planned throughout Germany,” indicating a widespread measure of some kind is still in motion.
Much of the government is at odds with any plan to minimize the original legalization plan. Said FDP member Kristine Lütke to Zeit Online, “We need Germany-wide legalization because the black market can only be pushed back if quality-assured cannabis for recreational use can be traded in certified shops throughout Germany. If you can only legally buy quality-assured cannabis in a few cities, the black market will survive.”
Hi, thanks for joining. Subscribe to our Cannadelics Weekly Newsletter to stay on top of everything; and to take advantage of deals on weed flowers, vapes & other smoking paraphernalia, edibles, cannabinoids (like delta-8), amanita mushroom extracts, and a load more. We’ve got all the good stuff here!
The original framework was set to allow adults 18 and up to purchase and have 20-30 grams of cannabis. The cannabis was supposed to be sold at government licensed stores, and possibly pharmacies as well. That initial framework, which was backed by the governing coalition, was also set to allow the self-cultivation of up to three plants.
The framework also spoke of adding an extra “special consumption tax” on cannabis products, alongside the country’s standard sales tax. This amount was not settled on, and the framework called for the tax amount to leave products at overall prices that can compete with the black market.
Though the government did pass this framework at the end of 2022, issues outside of Germany escalated when it came time for EU approval. And now it seems that this framework will likely get modified from its original version; to something more manageable for the EU.
Some possibilities of the new legislation
Whatever updates made to the framework are under wraps for now, but that doesn’t stop speculation from the peanut gallery of life. There are a couple unconfirmed thoughts as to the direction Germany will end up going with cannabis legalization.
Some think that self-cultivation will be instituted to a degree, with a push for cannabis clubs for more organized growing and dissemination. Think Spain, but as a more official model. Other ideas involve the implementation of sales though a pilot program, like in Denmark, or the one set to start in Switzerland. If the latter part is true, it indicates that a ‘wide-scale’ measure won’t mean ‘all encompassing’ of the country, and might only relate to certain areas.
Under this idea, the government would take its time to institute a full policy, as pilot trials tend to last several years. If Germany does adopt this method, a real legalization should not be expected for awhile, and nor should it be expected that the whole country will benefit from whatever is set up.
As nothing is confirmed about possible scale-back models, these are the main ideas swirling around right now. It’s thought these two ideas are relevant as they leave less polarizing issues for the EU to approve. In fact, the EU would only need to approve the first part, while the rest regarding cultivation and social clubs, would be only under Germany’s purview.
Truth is, we’ll have to wait until after Easter to find out for sure, and even that is actually questionable. According to Lauterbach, he is “firmly assuming that we will present the new proposal immediately after Easter,” which when you really look at the language, indicates we might not see something until after that time.
Problems with the EU, why this is happening
If it was only up to Germany, the conversation would be over; but there is another factor to consider. Germany is a member state of the EU, and operates like a state within a federal country. Which means, though it has its own government, it must also consider its federal parent organization, other countries of the EU, and international law as it applies to these bodies.
Germany made its announcement last year about legalizing recreational cannabis. It set up draft rules, introduced them, and approved them. But it did so with a heavy shadow hanging above; the need to get EU approval. According to the EU, cannabis with above .3% THC isn’t legal for recreational cultivation or sale, meaning Germany’s plans automatically don’t jive with EU mandate. So what happens when a country makes a decision outside of federal EU law? As no blueprint exists, its up to the EU to decide how to handle it.
When this came up last year as a possibly limiting factor; the country was split. Some wanted to push ahead and ignore the EU, others were more reticent to make such moves. Perhaps the EU is acting like an over-lording federal body trying to control its member country; but we should remember the EU has contracts with other countries related to drugs and commercial activities. The EU could put itself in hot water by allowing this. Plus, other countries like France are making a big stink, which adds more difficulty. France already lost its battle with the EU over blocking CBD imports from EU countries.
Though we don’t know what the EU said to Germany concerning the original draft law, there is wide concern for the legal discrepancy; with the EU as the main excuse for whatever revisions are underway. In fact, many in the industry are already resigned to this idea, as exemplified by Constantin von der Groeben, the managing director of cannabis company Demecan, based out of Berlin. According to von der Groeben via MJBizDaily:
“We have been expecting this result – a ‘model’ project – for several months and are therefore not surprised. Anything else would have been too difficult to align with EU regulation.” He continued that in terms of a trial program (if that’s what’s decided), “It might not even have to pass the Bundesrat. Legalization as early as January 2024, instead of the previously planned Q3 2024, would thus be possible.”
This understanding is mirrored by coalition partner the Social Democratic Party, which agrees that in the short term, a full legalization is not possible. In a statement issued last week, the Party said in reference to a trial program over a full legalization, “From our point of view, these can be model projects, decriminalization and self-cultivation.”
Conclusion
We won’t know until after Easter if the government will follow through with presenting something. And we won’t know until its presented, how modified the new plan is from the original, or what that means for a full-scale legalization in Germany. Best that we all let it go for now, unplug, and enjoy the holiday. We can get right back to it next week. Happy holiday, everyone!
Hey everyone! Welcome to Cannadelics.com; an independent publication where we work hard to deliver the very best in reporting for the cannabis and hallucinogens spaces. Come ’round regularly to remain updated on everything important; and check out the Cannadelics Weekly Newsletter, so you never miss a single thing.
Related
States are starting to scramble with looming budget deficients, but marijuana is a boon to some – especially one state.
The new federal administration is revamping how the government operates. With Doge, they are changing agencies and reducing services and support of states, which has left budget deficients in many. But some states have legal marijana and it has been a boon, for like alcohol…people are still consuming. States who are fully legal are making more money on weed than booze and this state’s cannabis revenue keeps pouring in. Missouri, the show me state, is being shown unexpected revenue.
RELATED: Mike Johnson And Marijuana
“Due to a strong cannabis market and effective, efficient regulation of that market,” Amy Moore, director of the Missouri Division of Cannabis Regulation, told The Independent this week, “the funds available for the ultimate beneficiaries of the cannabis regulatory program continue to outpace expectations.”
Funds will help veterans and other key projects. The other benefit is as seen in data from legal states, teen use is down so it frees up some other funds. Legal states are seeing benefits from legal cannabis including lower teen use and crime reduction.
States with legal cannabis are experiencing a significant boost in tax revenue, surpassing those generated by alcohol sales. This trend highlights the economic benefits of marijuana legalization, as cannabis markets expand and mature.
In California, cannabis excise taxes have consistently outperformed alcohol-related taxes, bringing in over double the revenue. Colorado has seen even more striking results, with marijuana tax revenues totaling seven times those of alcohol. Similarly, Massachusetts has collected more tax revenue from marijuana than alcohol since fiscal year 2021, marking a notable shift in state finances.
RELATED: Marijuana Use And Guy’s Member
Nationally, legal cannabis states generated nearly $3 billion in excise taxes on marijuana in 2021—20% more than alcohol taxes. By 2024, total adult-use cannabis tax revenue exceeded $20 billion, with states like Illinois and Washington reporting record-breaking contributions. Illinois alone collected $451.9 million from cannabis taxes in fiscal year 2022—one-and-a-half times the revenue from alcohol.
The funds are being put to good use. States like Illinois are channeling marijuana tax dollars into mental health services and community programs, while Colorado has invested nearly $500 million into public education. California has allocated millions to nonprofits addressing the impacts of the war on drugs.
This growing revenue stream underscores the potential of cannabis legalization to support vital public services and bolster state economies. As more states embrace regulated marijuana markets, the financial benefits are expected to continue flourishing.
The federal administration is all over the board around fed cannabis policy…and millions of patients are worried.
The industry employees over 440,000 workers at all lives and is driven in a large part by mom and pop businesses. Millions use medical marijuana for health issues ranging from chronic pain to sleep. But there are mixed messages from the feds about cannabis, and people are very worried. The federal government’s stance on marijuana has become increasingly complex, as recent developments show conflicting approaches to the drug’s potential benefits and risks. On one hand, there’s a push for research into medical marijuana for veterans, while on the other, a campaign against cannabis use is being launched.
RELATED: Music Is A Turn On Like Sex And Marijuana
The juxtaposition of initiatives highlights the federal government’s inconsistent approach to marijuana policy. While some departments are exploring the potential benefits of cannabis, others are actively working to discourage its use. This dichotomy is further exemplified by ongoing legislative efforts. For instance, Rep. Brian Mast (R-FL) has reintroduced the Veterans Equal Access Act, which would allow VA doctors to recommend medical marijuana to patients in states where it’s legal. Meanwhile, documents from an ongoing lawsuit suggest that the DEA may have weighted the marijuana rescheduling process to ensure rejection of moving the drug from Schedule 1 to Schedule 3.
The Department of Defense (DOD) has allocated nearly $10 million in funding for research into the therapeutic potential of MDMA for active-duty military members. This initiative, driven by congressional efforts, aims to explore MDMA’s effectiveness in treating conditions such as post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). Rep. Morgan Luttrell (R-TX) expressed pride in this development, stating that it could be a “game-changer” for service members battling these combat-related injuries.
Additionally, a bipartisan effort in Congress has been pushing for VA research on medical marijuana for PTSD and other conditions affecting veterans. The VA Medicinal Cannabis Research Act, introduced in both the Senate and House, would mandate studies on how cannabis affects the use of addictive medications and impacts various health outcomes for veterans.
RELATED: The Science Behind Why Music Sounds So Much Better When You’re High
In stark contrast to these research initiatives, the Drug Enforcement Administration (DEA) has partnered with an anti-cannabis nonprofit to launch a social media campaign targeting young people. The campaign, set to run ahead of April 20 (4/20), aims to “flood” Instagram with anti-cannabis content. The DEA is offering monetary incentives to students for creating and posting anti-THC videos, with payments ranging from $25 to $50 depending on the type of content produced.
This approach has raised eyebrows, as it seems to contradict the growing acceptance and legalization of marijuana across the United States. Critics argue that such campaigns may be out of touch with current societal trends and scientific understanding of cannabis.
Not everyone has access to marijuana to help them sleep – good news, hemp is available.
RELATED: Mike Johnson And Marijuana
Hemp contains several compounds contributing to better sleep quality. Cannabidiol (CBD), a non-psychoactive component of hemp, has shown potential in promoting relaxation and reducing anxiety, which can often interfere with a good night’s rest. Studies suggest that CBD may help individuals fall asleep faster and experience fewer sleep disturbances throughout the night.
When formulated and used properly, preliminary research and user reports suggest that hemp gummies improve subjective sleep quality. Users of quality hemp sleep gummies report feeling more rested, a better quality of sleep and fewer awakenings in the night. However, clinical research has shown that over consumption of THC negatively impacts the quality of sleep, especially with long term use.
Wana Brands has launched a hemp sleeping product nationally, Mike Hennesy, Vice President of Innovation shared the following about how it works. Naturally hemp-derived sleep gummies contain the same cannabinoids like CBD, CBN, and THC as cannabis or marijuana. These ingredients interact with receptors in the body’s endocannabinoid system, which plays a role in regulating mood, stress, and sleep-wake cycles. For example, CBD may promote relaxation and reduce anxiety, CBN can relieve discomfort and reduce awakenings, while THC can shorten the time it takes to fall asleep, especially at low doses. Together, they may help ease the mind and body into a sleep-ready state.
The best sleep products don’t rely on just one cannabinoid like CBN but instead use a combination of cannabinoids, terpenes, and other sleep-supporting ingredients such as melatonin. This is because the reasons for sleeplessness are multifaceted, and include trouble falling asleep, staying asleep, chronic, pain and anxiety. Each ingredient targets different root causes as well as synergizes with the other cannabinoids and terpenes for the best night sleep.
Longer lasting formulations can actually help reduce awakenings in the night. CBN has been shown in recent research to reduce the number of times you wake up in the night. Combined with other cannabinoids they can synergize to reduce discomfort and anxiety helping consumers stay asleep.
RELATED: Marijuana Use And Guy’s Member
If you do wake up in the middle of the night and can’t fall back asleep products including CBD and CBG to reduce middle of the night anxiety and racing thoughts that can keep us awake, and they have only 1mg of THC so you wake up refreshed and not high in the morning.
For most people, hemp-derived cannabinoids are considered safe and non-intoxicating, with a low risk of dependence. When THC is included in small amounts, it can produce mild effects and can help us fall asleep faster. It generally poses a minimal risk when used in moderation, but there is a potential for dependence if overused, just like with any sleep aid. Adverse events are far more prevalent in pharmaceutical and even over the counter sleep aids than with hemp-derived cannabinoids.
The key is responsible use, including starting with a low dose and taking breaks when needed. If you rely on it every night at high doses, your body may adjust, and it can be habitual. But when used in moderation and with a well-balanced formula, cannabis can be a sustainable part of a healthy sleep routine.
Does Comfort Food Actually Help
Connect to cannabis history with three legacy strains from Paradise Seeds
This State’s Cannabis Revenue Keeps Pouring In
Major Bloom: Cultivating community, creativity, and cannabis in Worcester
How a Colorado operator stumbled onto ‘blueprint for laundering marijuana’
Northern Ireland: Man charged after £425,000 worth of cannabis seized
Getting THC Edibles in Your Edible Arrangement?
Is Cannabis Legal in California Right Now?
Germany: Trial against operator of Trier cannabis vending machine discontinued
The best energizing THC gummies of 2025 by Leafly
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
UArizona launches online cannabis compliance online course
-
Cannabis News2 years agoDistressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years agoUnited States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years agoWhat you Need to Know
-
drug testing1 year agoDrug Testing for Marijuana – The Joint Blog
-
Education2 years agoNCIA Write About Their Equity Scholarship Program
-
Cannabis2 years agoIt has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years agoCannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years agoA new April 20 cannabis contest includes a $40,000 purse